Key facts
- Notable investors include Changzhou Honghui Holding Group, Ruitai Venture Capital.
- Status: Privately Held (backing).
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for BioScene Pharma
- ·The full record, as it builds
Funding rounds
No funding rounds for BioScene Pharma are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About BioScene Pharma
Developer of pharmaceutical solutions designed for improved new drugs and high-end generic medicines. The company provides advanced drug delivery systems and AI-powered research services, enabling global pharmaceutical industry users with innovative R&D and technology transfer solutions.
- Sector
- Healthcare
- HQ
- Changzhou, China
- Founded
- 2020
- Website
- bioscenepharma.com/
- Ownership
- Privately Held (backing)
BioScene Pharma doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in BioScene Pharma shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on BioScene Pharma in its N-PORT filings yet. We sweep new filings monthly.